Physician profile
Matthew Daka
NPI 1598985715
$16,064.09
in general payments reported to CMS, 2019-2025
41 companies · $10K in 2025
The $10K reported for 2025 was more than what 89% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,544 · 2020: $1,185 · 2021: $442 · 2022: $627 · 2023: $973 · 2024: $800 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $10K · Food and Beverage: $2,251 · Entertainment: $14.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $10,000.00 |
| Food and Beverage | $2,251.35 |
| Entertainment | $14.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $10,191.82 | 2020-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Cardiovascular Systems INC. | $1,311.09 | 2019-2022 | |
| Edwards Lifesciences Corporation | $1,297.77 | 2019-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| E.R. Squibb & Sons, L.L.C. | $491.72 | 2022-2025 | Camzyos, Eliquis |
| Baxter Healthcare | $307.61 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $276.36 | 2019-2025 | Lifevest |
| Abbott Laboratories | $215.22 | 2021-2025 | Merlin@Home, Jot Dx |
| Merck Sharp & Dohme LLC | $210.58 | 2021-2025 | Verquvo |
| Pfizer INC. | $198.94 | 2019-2025 | |
| Irhythm Technologies, INC. | $189.64 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Boston Scientific Corporation | $183.40 | 2021-2025 | Watchman, Avvigo Guidance System, Watchman Flx |
| Janssen Pharmaceuticals, INC | $175.30 | 2019-2024 | Xarelto |
| Medtronic, INC. | $138.64 | 2021-2024 | Claria Mri Quad Crt-D Surescan, Cobalt Dr Mri Surescan, Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $126.90 | 2021-2023 | |
| Abiomed | $117.02 | 2019-2025 | Impella |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $68.32 | 2022-2023 | Opsumit, Uptravi |
| Philips North America LLC | $46.14 | 2024 | (Ck7) Extended Holter, (Br0) Coronary Atherectomy |
| Cashflow Solutions, LLC | $40.21 | 2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Novo Nordisk INC | $37.25 | 2023-2025 | Wegovy, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.03 | 2019-2025 | Jardiance |
| Inspire Medical Systems, INC. | $31.72 | 2023-2024 | Inspire |
| Alnylam Pharmaceuticals INC. | $25.28 | 2023 | |
| Cardiva Medical, INC. | $24.98 | 2023 | Cardiva Vascade 6/7f Vcs |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $23.89 | 2019 | |
| Celgene Corporation | $23.63 | 2024 | Camzyos |
| Sanofi-Aventis U.S. LLC | $22.06 | 2019 | |
| Vital Connect, INC | $20.88 | 2025 | Vitalpatch Rtm |
| Veryan Medical Incorporated | $20.61 | 2021 | |
| Teleflex LLC | $19.88 | 2024 | Vascband |
| Biotronik INC. | $19.41 | 2022 | |
| Scpharmaceuticals INC. | $18.42 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $17.86 | 2023 | Inpefa |
| Amarin Pharma, INC. | $17.71 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $17.27 | 2021 | |
| Esperion Therapeutics, INC. | $16.75 | 2024 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $15.08 | 2022 | |
| Medtronic Vascular, INC. | $14.86 | 2019 | |
| Opsens INC. | $14.47 | 2023 | Optowire |
| Cardiofocus, INC. | $14.20 | 2019 | |
| Kestra Medical Technology Services, INC. | $14.13 | 2024 | Assure Wcd |
| Shockwave Medical, INC | $12.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Daka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.